This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
We have now added a new section called the "Assay History List" to the "At A Gla...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...